Background Cardiorespiratory impairments are considered the main cause of mortality in the late stages of Parkinson's. Aerobic exercise has been shown to improve pulmonary function in asthmatic patients and in healthy people. However, effects of aerobic exercise on cardiopulmonary function in people with Parkinson's have not been investigated. Therefore, this study aimed to review the effects of aerobic exercise on cardiopulmonary function in people with Parkinson's. Method A systematic search was conducted using MEDLINE, AMED, and CINHAL Plus, and relevant associated keywords, from January 1970 to January 2020. Inclusion criteria for the studies were: aerobic exercise as part of the intervention, pulmonary function test and/or cardiop...
Abstract Introduction: Respiratory function changes in patients with Parkinson’s disease (PD) contr...
Objectives: To investigate the acute and adaptation cardiovascular and metabolic training responses ...
Respiratory dysfunction has been associated with Parkinson’s disease since it was first described in...
Background: Cardiorespiratory impairments are considered the main cause of mortality in the late sta...
Introduction Cardiopulmonary impairments are the leading cause of morbidity and mortality in advanc...
Abstract Background: Patients with Parkinson’s disease (PD) are struggling to maintain their quality...
Background: Parkinson’s disease is a chronic neurodegenerative disorder mainly known for its motor s...
Background/aim: Parkinsonism is a neurodegenerative disease affecting approximately 10 million patie...
Although some trials assessed the effectiveness of aerobic exercise for Parkinson's disease (PD), th...
Although some trials assessed the effectiveness of aerobic exercise for Parkinson's disease (PD), th...
Background: Although some trials assessed the effectiveness of aerobic exercise for Parkinson’s dise...
BACKGROUND: Signs of respiratory dysfunction can be present already early in the course of Parkinson...
Introduction: Parkinson’s Disease (PD) is classified as a movement disorder exhibiting symptoms of s...
Ailish O’Callaghan,1 Richard Walker2,3 1Department of Medicine, North Cumbria University Hospi...
Abstract Introduction: Respiratory dysfunction is the main cause of death in Parkinson's disease (P...
Abstract Introduction: Respiratory function changes in patients with Parkinson’s disease (PD) contr...
Objectives: To investigate the acute and adaptation cardiovascular and metabolic training responses ...
Respiratory dysfunction has been associated with Parkinson’s disease since it was first described in...
Background: Cardiorespiratory impairments are considered the main cause of mortality in the late sta...
Introduction Cardiopulmonary impairments are the leading cause of morbidity and mortality in advanc...
Abstract Background: Patients with Parkinson’s disease (PD) are struggling to maintain their quality...
Background: Parkinson’s disease is a chronic neurodegenerative disorder mainly known for its motor s...
Background/aim: Parkinsonism is a neurodegenerative disease affecting approximately 10 million patie...
Although some trials assessed the effectiveness of aerobic exercise for Parkinson's disease (PD), th...
Although some trials assessed the effectiveness of aerobic exercise for Parkinson's disease (PD), th...
Background: Although some trials assessed the effectiveness of aerobic exercise for Parkinson’s dise...
BACKGROUND: Signs of respiratory dysfunction can be present already early in the course of Parkinson...
Introduction: Parkinson’s Disease (PD) is classified as a movement disorder exhibiting symptoms of s...
Ailish O’Callaghan,1 Richard Walker2,3 1Department of Medicine, North Cumbria University Hospi...
Abstract Introduction: Respiratory dysfunction is the main cause of death in Parkinson's disease (P...
Abstract Introduction: Respiratory function changes in patients with Parkinson’s disease (PD) contr...
Objectives: To investigate the acute and adaptation cardiovascular and metabolic training responses ...
Respiratory dysfunction has been associated with Parkinson’s disease since it was first described in...